Skip to main content

Elisabet Miro Casas

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Elisabet Miro Casas

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Elisabet Miro Casas, Marisol Ruiz Meana, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Fundación Eugenio Rodríguez Pascual
Funding: 25000
Reference: FERP/2024/RODRIGUEZ
Duration: 15/01/2025 - 14/01/2027

Role of amino acid metabolism reprogramming and calpain deregulation in fibroblasts activation and diffuse myocardial fibrosis in heart failure

IP: Javier Inserte Igual
Collaborators: José Antonio Barrabés Riu, David Aluja Gonzalez, Juan Garrido Oliver, Elisabet Miro Casas, Sara Delgado Tomás
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI23/00068
Duration: 01/01/2024 - 31/12/2026

Daño mitocondrial por estrés dicarbonílico como impulsor de la senescencia: papel de los senolíticos en la protección del corazón durante el envejecimiento.

IP: Marisol Ruiz Meana
Collaborators: Rafael Rodríguez Lecoq, David Aluja Gonzalez, Elisabet Miro Casas
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI22/00513
Duration: 01/01/2023 - 31/12/2025

Personal Investigador para Grupo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Alba Santos Ortega, José Antonio Barrabés Riu, Maria Vidal Burdeus, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Teresa González Alujas, Begoña Benito Villabriga, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Victor Gonzalez Fernandez, Guillem Casas Masnou, David Aluja Gonzalez, Bernat Serra Creus, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Aitor Uribarri Gonzalez, Imanol Otaegui Irurueta, Jordi Bañeras Rius, Bruno García del Blanco, Ruperto Olivero Soldevila, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Jordi Lozano Torres, Ana Belén Méndez Fernández, Berta Miranda Barrio, Gerard Oristrell Santamaria, Pau Rello Sabaté, Toni Soriano Colomé, Jaume Francisco Pascual, Aleix Olivella San emeterio, Sara Delgado Tomás, Aroa Ruiz Muñoz, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Javier Limeres Freire, Irene Buera Surribas, Ruben Fernández Galera, Raul Aguilar Lopez, Alvaro Calabuig Goena, Lydia Dux-Santoy Hurtado, Laura Galián Gay, Laura Dos Subirá, Maria Nazarena Pizzi, Filipa Xavier De Carvalho Negrao Valente, Andrea Guala
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00758
Duration: 01/01/2022 - 30/06/2025

Related news

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

In light of this evidence, hospitals such as Vall d'Hebron have already started to include warnings about environmental pollution in their hospital discharge plans after a myocardial infarction.

Vall d'Hebron researchers have created a score based on multiple clinical variables and cardiac images, specific to women, to identify patients at risk of severe complications such as a heart attack or sudden death.

Related professionals

Masotto , Barbara

Masotto , Barbara

Predoctoral researcher
Genetics Medicine
Read more
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Rheumatology
Read more
Pablo Eduardo Tobias Castillo

Pablo Eduardo Tobias Castillo

Predoctoral researcher
Cardiovascular Diseases
Read more
Carmen Folch Badiella

Carmen Folch Badiella

Research technician
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.